StonvexLoading…
StonvexStonvexStonvexCore line items from IX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | ¥1.35T | ¥1.30T | ¥1.30T | ¥1.25T |
Operating Income | ¥331.83B | ¥360.71B | ¥335.92B | ¥292.88B |
Net Income | ¥351.63B | ¥346.13B | ¥290.34B | ¥317.38B |
EPS (Diluted) | ¥307.16 | ¥298.05 | ¥245.65 | ¥263.42 |
Total Assets | ¥16.87T | ¥16.32T | ¥15.29T | ¥14.28T |
Total Liabilities | ¥12.69T | ¥12.30T | ¥11.67T | ¥10.90T |
Cash & Equivalents | ¥1.21T | ¥1.03T | ¥1.23T | ¥954.83B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 1.14B | 1.16B | 1.18B | 1.20B |